| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
55 |
| issn |
1523-3782
1534-3170 |
| issueIdentifier |
1 |
| pageRange |
53-55 |
| publicationName |
Current Cardiology Reports |
| startingPage |
53 |
| bibliographicCitation |
McAnulty JH. Is optimal antithrombotic therapy after myocardial infarction well defined? Curr Cardiol Rep. 2001 Jan;3(1):53–5. doi: 10.1007/s11886-001-0010-4. PMID: 11139799. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94873b0e394c96d715b2c7bc17a24a03 |
| date |
200101 |
| identifier |
https://doi.org/10.1007/s11886-001-0010-4
https://pubmed.ncbi.nlm.nih.gov/11139799 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1523-3782
https://portal.issn.org/resource/ISSN/1534-3170
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21832 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Is optimal antithrombotic therapy after myocardial infarction well defined? |
| discusses |
http://id.nlm.nih.gov/mesh/M0001864
http://id.nlm.nih.gov/mesh/M0022871
http://id.nlm.nih.gov/mesh/M0017012
http://id.nlm.nih.gov/mesh/M0001380 |